This in turn helps promote member safety and contain costs
It is typically used to stimulate the production of growth hormone (GH) in the body, which can help to promote weight loss
GLP-1 concentrations are reduced in patients with type 2 diabetes in response to a meal, while GIP concentrations are either normal or increased, suggesting a resistance to the actions of GIP thus making GLP-1 a more logical target for therapeutic intervention.[26][27] Brown and colleagues isolated the first incretin from cholesystokinin in 1971, and named it gastric inhibitory peptide (GIP)
This multifaceted approach makes GLP-1 receptor agonists effective not only for managing diabetes but also for promoting weight loss in individuals with obesity
Direct absorption through the oral mucosa makes sublingual preparations particularly reliable when regular capsules or tablets are not sufficient for swallowing
Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, et al